课题基金 / 基金详情

CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE

CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
核心--口服重组沙门氏菌抗生育疫苗核心
批准号:
3779295
负责人:
ROY CURTISS
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ROY CURTISS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ultimate goal is to construct one or more safe, efficacious, recombinant avirulent Salmonella vaccine strains, each expressing one or more sperm- or egg-specific antigens that would, upon oral immunization, induce immune responses to inhibit and/or prevent the fertilization process. In general, species of Salmonella will be attenuated by introduction of delta/cya/delta/crp mutations, and further modified to decrease survivability in blood, to be excreted in a totally avirulent nonimmunogenic form with reduced survival in nature and minimal probability for causing immunization of those not elected to be immunized. Genetic information for expression of sperm-specific and egg-specific antigens will be contained on multi-copy plasmid vectors of the balanced lethal type, wherein the asd+ gene on the vector complements a delta/asd chromosomal mutation imposing a requirement for diaminopimelic acid (DAP). Genetic information defining important sperm-specific and egg-specific antigens will be based on studies being conducted by other Center members as well as by other scientists conducting related research. The vectors with DNA inserts will be designed and constructed to enhance transcription and translation and to reduce breakdown of the protein product. We will also employ the best available methods to enhance and/or restrict the type of immune response by inclusion of sequences encoding adjuvants, immune enhancers and/or modulators and specific epitopes to enhance SIgA mucosal or IgG humoral or various cellular immune responses. The various constructs will be evaluated in a diversity of in vitro tests and the S. typhimurium and S. choleraesuis derivatives for stability and immunogenicity in mice and rabbits. Suitable S. typhi and S. paratyphi A constructs will also be made for use with primates and ultimately humans. The research will make use of modern technologies in the fields of microbiology, immunology, genetics, molecular biology and animal sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
  • 批准号:
    5212802
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROY CURTISS
  • 依托单位:
    --
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
  • 批准号:
    3843084
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROY CURTISS
  • 依托单位:
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
  • 批准号:
    3757366
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROY CURTISS
  • 依托单位:
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
  • 批准号:
    3735617
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROY CURTISS
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究